# Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma

> **NCT03086681** · PHASE2 · COMPLETED · sponsor: **Yong Zhang,MD** · enrollment: 120 (actual)

## Conditions studied

- Cervical Carcinoma

## Interventions

- **DRUG:** Endostar
- **DRUG:** DDP

## Key facts

- **NCT ID:** NCT03086681
- **Lead sponsor:** Yong Zhang,MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-20
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086681, "Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03086681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*